MyAverix Finance MyAverix Finance

OL · Healthcare

Gentian Diagnostics AS (GENT)

Medical Devices

Gentian Diagnostics AS (GENT) is listed on OL in the Healthcare sector. Industry: Medical Devices. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for GENT

P/E ratio
18.00

Gentian Diagnostics AS (GENT) — FAQ

What is GENT's P/E ratio?

The price-to-earnings (P/E) ratio for Gentian Diagnostics AS (GENT) is 18.00 (data as of 2026-05-24).

Does Gentian Diagnostics AS pay a dividend?

Dividend yield is not available in the current snapshot for Gentian Diagnostics AS (GENT). Check the MyAverix Finance app for the latest dividend data.

What sector is Gentian Diagnostics AS in?

Gentian Diagnostics AS (GENT) is classified in the Healthcare sector (Medical Devices industry).

What exchange is GENT listed on?

GENT is listed on OL.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play